Novo Nordisk A/S (NONOF)
43.86
-1.01
(-2.25%)
USD |
OTCM |
Jun 16, 16:00
Novo Nordisk SG&A Expense (Quarterly) : 2.070B for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.070B |
| December 31, 2025 | 2.718B |
| September 30, 2025 | 2.799B |
| June 30, 2025 | 2.865B |
| March 31, 2025 | 2.273B |
| December 31, 2024 | 2.900B |
| September 30, 2024 | 2.443B |
| June 30, 2024 | 2.322B |
| March 31, 2024 | 2.098B |
| December 31, 2023 | 2.686B |
| September 30, 2023 | 2.054B |
| June 30, 2023 | 2.252B |
| March 31, 2023 | 1.944B |
| December 31, 2022 | 2.069B |
| September 30, 2022 | 1.706B |
| June 30, 2022 | 1.693B |
| March 31, 2022 | 1.682B |
| December 31, 2021 | 1.970B |
| September 30, 2021 | 1.608B |
| June 30, 2021 | 1.444B |
| March 31, 2021 | 1.488B |
| December 31, 2020 | 1.756B |
| September 30, 2020 | 1.441B |
| June 30, 2020 | 1.215B |
| March 31, 2020 | 1.256B |
| Date | Value |
|---|---|
| December 31, 2019 | 1.596B |
| September 30, 2019 | 1.307B |
| June 30, 2019 | 1.269B |
| March 31, 2019 | 1.195B |
| December 31, 2018 | 1.529B |
| September 30, 2018 | 1.257B |
| June 30, 2018 | 1.270B |
| March 31, 2018 | 1.207B |
| December 31, 2017 | 1.489B |
| September 30, 2017 | 1.168B |
| June 30, 2017 | 1.128B |
| March 31, 2017 | 1.104B |
| December 31, 2016 | 1.315B |
| September 30, 2016 | 1.181B |
| June 30, 2016 | 1.175B |
| March 31, 2016 | 1.130B |
| December 31, 2015 | 1.350B |
| September 30, 2015 | 1.177B |
| June 30, 2015 | 1.195B |
| March 31, 2015 | 1.056B |
| December 31, 2014 | 1.300B |
| September 30, 2014 | 1.203B |
| June 30, 2014 | 1.168B |
| March 31, 2014 | 1.082B |
| December 31, 2013 | 1.379B |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 2.934B |
| ALK-Abello A/S | 79.40M |
| H. Lundbeck A/S | 334.19M |
| Dr. Reddy's Laboratories Ltd. | 303.26M |
| Teva Pharmaceutical Industries Ltd. | 997.29M |